<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The purpose of this study was to evaluate the expression of cyclin A1 <z:chebi fb="2" ids="33699">mRNA</z:chebi> in patients with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) and its clinical significance </plain></SENT>
<SENT sid="1" pm="."><plain>The expression of cyclin A1, cdk2 and p21(cip1) <z:chebi fb="2" ids="33699">mRNA</z:chebi> in the bone marrow from 56 patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and 10 <z:mpath ids='MPATH_458'>normal</z:mpath> control were measured by using reverse transcription polymerase chain reaction (RT-PCR) technique </plain></SENT>
<SENT sid="2" pm="."><plain>The results indicated that the positive rate and the expression level of cyclin A1 in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients (69.64%; 0.964 +/- 1.879) were significantly higher than those in <z:mpath ids='MPATH_458'>normal</z:mpath> control (0%; 0.012 +/- 0.014) (p &lt; 0.01) </plain></SENT>
<SENT sid="3" pm="."><plain>Among de-novo <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients, the expression level of cyclin A1 <z:chebi fb="2" ids="33699">mRNA</z:chebi> in the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> group (1.895 +/- 1.769) was higher than that in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-RA group (0.629 +/- 1.583) (p &lt; 0.01) </plain></SENT>
<SENT sid="4" pm="."><plain>The expression level of cyclin A1 <z:chebi fb="2" ids="33699">mRNA</z:chebi> in post-treatment group was significantly lower than that in prior-treatment group (p &lt; 0.01) </plain></SENT>
<SENT sid="5" pm="."><plain>It is concluded that the <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression of cyclin A1 in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients is higher than that in <z:mpath ids='MPATH_458'>normal</z:mpath> control, the abnormal expression of cyclin A1 may be used as a prognostic marker in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients </plain></SENT>
</text></document>